Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0F4QX
|
||||
Former ID |
DNC003338
|
||||
Drug Name |
Thenoyltrifluoroacetone
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C8H4F3O2S-
|
||||
Canonical SMILES |
C1=CSC(=C1)C(=CC(=O)C(F)(F)F)[O-]
|
||||
InChI |
1S/C8H5F3O2S/c9-8(10,11)7(13)4-5(12)6-2-1-3-14-6/h1-4,12H/p-1/b5-4-
|
||||
InChIKey |
NRUKQBVKKFFCSN-PLNGDYQASA-M
|
||||
CAS Number |
CAS 326-91-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Liver carboxylesterase | Target Info | Inhibitor | [1] | |
KEGG Pathway | Drug metabolism - other enzymes | ||||
Metabolic pathways | |||||
Pathway Interaction Database | E2F transcription factor network | ||||
WikiPathways | NRF2 pathway | ||||
Nuclear Receptors Meta-Pathway | |||||
Heroin metabolism | |||||
Irinotecan Pathway | |||||
Fluoropyrimidine Activity | |||||
Phase I biotransformations, non P450 | |||||
References | |||||
REF 1 | Zhang JG, Fariss MW: Thenoyltrifluoroacetone, a potent inhibitor of carboxylesterase activity. Biochem Pharmacol. 2002 Feb 15;63(4):751-4. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.